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Abstract The glycine receptor is a figand-gated anion channel 
protein of postsynaptic membranes. We expressed a homo-oli- 
gomeric receptor composed of human a l  subunits in Spodoptera 
frugiperda cells by infection with a recombinant Autographa cal- 
ifornica nuclear polyhedrosis virus. A substantial fraction of the 
recombinant receptor was incorporated as a functional channel 
protein into the cell's plasma membrane at expression levels 4- 
to 30-fold higher than in other eukaryotic heterologous expres- 
sion systems or native rat spinal cord membranes, respectively. 
Upon detergent solubilization, the a l  receptor was found to exist 
in a predominantly monodisperse state and could be affinity- 
purified to near homogeneity. This preparation is a potential 
starting point for future crystallisation studies. 
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transmembrane topology characterized by an extended N-ter- 
minal extracellular domain followed by four transmembrane 
segments (M1-M4; see [1]). 
Here, we expressed a l  homo-oligomeric GlyR in Spodoptera 
frugiperda (Sf9) insect cells infected with a recombinant Auto- 
grapha californica baculovirus, in which the GlyR a l  cDNA 
was placed under the control of the polyhedrin promoter. The 
baculovirus Sf9 cell system was previously used to overexpress 
the c~l GlyR [7] in order to produce preparative amounts of 
GlyR protein. Receptor purification described in that study 
involved solubilisation with digitonin/desoxycholate nd re- 
sulted in a partially proteolysed protein. Here we used solubil- 
isation of the receptor with the more economical conventional 
detergent Triton X-100 and affinity-purified it to a nearly ho- 
mogenous and monodisperse tate, which appears uitable for 
crystallization studies. 
1. Introduction 
The inhibitory glycine receptor (GlyR) is a member of the 
ligand-gated ion channel superfamily which includes nicotinic 
acetylcholine, y-aminobutyric a id A-type and 5-HT3 serotonin 
receptors. The intrinsic ion channel of these proteins is acti- 
vated in response to agonist binding and thus mediates fast 
synaptic transmission. The GlyR can be detected by radioli- 
gand binding assays using the selective antagonist, [3H]strych- 
nine, and affinity chromatography onaminostrychnine agarose 
columns yields highly purified GlyR preparations. In analogy 
to other neurotransmitter r ceptors, the GlyR was found to be 
a pentameric molecule consisting of homologous ligand-bind- 
ing ~ (~1-¢z4) and modulatory fl-subunits (for review, see [1]). 
Transient heterologous expression i eukaryotic cell systems, 
such as Xenopus laevis oocytes or HEK-293 cells, creates func- 
tional a homo-oligomeric or otlfl heterooligomeric receptors 
depending on the type(s) of subunit(s) expressed. The anion 
channel of these recombinant receptors i gated by the agonists 
glycine, fl-alanine or taurine; binding of these ligands is compet- 
itively inhibited by strychnine [2-5]. The recombinant receptors 
display a sedimentation behaviour indistinguishable from that 
of native GlyR [6], suggesting that a pentameric quaternary 
structure is preserved upon heterologous expression. Hydropa 7
thy analysis of a and fl subunit primary structure predicts a 
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2. Materials and methods 
2.1. Viruses and cells 
Wild-type Autographa californica nuclear polyhedrosis virus 
(AcNPV) and recombinant viruses were propagated in Spodoptera 
frugiperda (Sf9) cells at 27°C in IPL-61 medium (Gibco) supplemented 
with 10% (v/v) heat-inactivated f tal calf serum, amphotericin (2.5 
mg/ml) and gentamycin (50 mg/ml) [8]. The Sf9 cell line was maintained 
in monolayer culture and split for propagation every 6 days. For large- 
scale infection, cells were grown in suspension at 27°C with gently 
stirring in 1 litre glass bottles. For GIyR expression, cells were infected 
with recombinant AcNPV at a multiplicity of infection of 5-10. Cells 
were harvested for assays 2-4 days later. The AcNPV baculovirus, the 
insect Sf9 cells, and the transfer plasmid pVL1393 were purchased from 
Invitrogen. 
2.2. Construction of the transfer vector 
The baculovirus transfer vector, pVL1393 was modified as follows 
to yield the transfer vector pVLGlyRal. A NheI restiction site was 
created immediately upstream from the initiator ATG of the human al 
GlyR cDNA [9] by site-directed mutagenesis (Amersham InVitro Mut- 
agenesis System II), using the oligonucleotide: 5'-GCACAAAGGAC- 
CGCTAGCATGTACAGC-3'. The coding region of the mutated ~1 
GlyR cDNA was excised by NheI/XbaI digestion and ligated into the 
XbaI site of pVL1393. 
2.3. Transfection and isolation of recombinant virus 
To achieve homologous recombination between wild-type (wt) virus 
and the transfer vector, Sf9 cells were co-transfected with 1 /2g of 
AcNPV DNA and 2/2g of the transfer vector pVLGlyR~I, using the 
calcium phosphate method [8]. Following a 7 day incubation at 27 ° C, 
recombinant baculoviruses were isolated by limited ilution. After sav- 
ing the virus-containing supernatants, cell clones were solubilized with 
150 mM NaC1, 50 mM Tris-HC1, pH 7.4, 20% (v/v) methanol, 2% (w/v) 
sodium desoxycholate and protease inhibitors as described [10], trans- 
ferred onto a nitrocellulose membrane and analysed for GlyR-specific 
immunoreactivity using a dot assay with mAb4 [11,12]. In addition, 
GlyR al sequences were detected by dot-blot hybridisation with a 
randomly primed 32p-labeled GIyR ~1 eDNA fragment encoding the 
entire reading frame. 
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The virus supernatants of those samples that were immunopositive 
and hybridised with the 3~p-labeled probe, were subjected to three more 
rounds of dilution, infection and identification. Thus, singular clones 
of recombinant viruses were obtained, which were devoid of polyhedrin 
protein as detected by visual inspection. 
2.4. Gel electrophoresis, Western blotting and immuno-fluorescence 
SDS-PAGE on 12% gels was followed either by silver staining [13] 
or by Western blot analysis with monoclonal antibody mAb4 as de- 
scribed [6]. Immuno-fluorescence staining was done on Sf9 cells grown 
on 12 mm coverslips (Thermanox, Nunc) as described [14]. Cells were 
stained with mAb2 [11] in the unpermeabilised state, or fixed with 
methanol and stained with mAb4. 
2.5. [XH]Strychnine binding assay 
Agonist displaceable binding of [3H]strychnine to homogenates of
crude Sf9 cell membranes or solubilised receptor preparations was 
determined as described [15]. 
2.6. Whole-cell recording 
For electrophysiological experiments, Sf9 cells were grown on 12 mm 
glas coverslips in a 24-well plate. Three days after infection, glycine- 
gated whole cell currents were analysed in the voltage-clamp mode of 
the whole cell patch configuration as described previously [5]. 
2. 7. Sucrose density gradient centrifugation 
Detergent extract containing about 3 pmol [3H]strychnine binding 
sites was sedimented through a 12.5 ml sucrose gradient (5~0%, w/w), 
and fractions were assayed for mAb4 immunoreactivity [6]. The follow- 
ing marker enzymes were analyzed in a parallel gradient: cytochrome 
e (1.8 S), malate dehydrogenase (4.32 S), lactate dehydrogenase (6.95 
S), catalase (11.3 S), and fl-galactosidase (15.9 S). 
2.8. Purification by affinity chromatography 
Purification of the GIyR from infected Sf9 cells was done according 
to the published procedure [10]. Briefly, cells grown in suspension were 
pelleted at 1000 x g and homogenized using a glass homogeniser (10 
strokes). The homogenate was centrifuged with a maximal acceleration 
of 10000 x g, which proved important for subsequent solubilisation. 
The membrane pellet was homogenised in 25 mM potassium phosphate 
buffer: pH 7.4, 0.2 M KC1, 5 mM dithiothreitol, and protease inhibitors 
(see [10]) at a protein concentration of4 mg/ml and solubilised at 4°C 
for 1 h after adding 2% (w/v) Triton X-100 (Serva) and 1 M KC1. After 
centrifugation at 100000 x g and filtering, the solubilisate was applied 
onto a 2-aminostrychnine agarose column and washed with 50 bed- 
volumes of 25 mM potassium phosphate buffer, pH 7.4, 1 M KC1, 1% 
(w/v) Triton X-100, 5 mM dithiothreitol and protease inhibitors. The 
purified GlyR was eluted with 2 bed-volumes of200 mM glycine in the 
washing buffer. 
3. Results 
3.1. Isolation of recombinant GlyR otl baculovirus 
For the construction of recombinant virus, the coding region 
of the human GlyR ~1 subunit cDNA was inserted into the 
baculovirus transfer vector pVL1393 and co-transfected with 
wild-type AcNPV virus DNA into Sf9 cells. Several recombi- 
nant virus clones were identified that were positive in both 
DNA hybridization and immunoblot analysis. Here we de- 
scribe the characterisation f clone G6, which showed the high- 
est expression level. 
3.2. Immunological nd pharmacological characterisation 
Western blot analysis with mAb4 revealed that membranes 
of  Sf9 cells infected with recombinant baculovirus clone G6 
contained an immunoreactive protein with an apparent molec- 
ular weight of 48 kDa, i.e. that of the GlyR a subunit detected 
in rat spinal cord membranes (Fig. 1A). However, staining 
intensities in the Sf9 membranes significantly exceeded that of 
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Fig. 1. Identification ofc~l GIyR in Sf9 cells infected with an isolate of 
recombinant baculovirus (clone G6). (A) Western blot analysis of Sf9 
and rat spinal cord (sc) membranes (5 ¢tg of protein/lane). After SDS- 
PAGE and blotting, the protein was immuno-stained with mAb4, spe- 
cific for GlyR ~-subunits. The difference in staining intensity between 
spinal cord and Sf9 cell membranes reflects the different levels of GlyR 
expression. (B) [3H]Strychnine bi ding to Sf9 cell membranes infected 
with G6 or wt virus. Binding of 25 nM [3H]strychnine tothe membranes 
was competed for by glycine (10 mM), fl-alanine (10 raM) or taurine 
(10 mM). Cells infected with wt virus show no specific [3H]strychnine 
binding. (C) Quantitation of radioligand binding. Upon incubation of 
G6 infected Sf9 cell membranes with [3H]strychnine at concentrations 
ranging from 2 to 200 nM, saturable binding could be demonstrated 
(inset: saturation curves with and without 10 mM glycine; • = total 
binding; A = unspecific binding; • = specific binding). Transformation 
of the data according to Scatchard yielded a dissociation constant (Ka) 
of 38.5 nM and a maximal number of[3H]strychnine binding sites (Bin,x) 
of 71 pmol/mg protein. The data points are derived from the means of 
a measurement done in triplicate. 
spinal cord, which is consistent with a higher GlyR expression 
level in the former (see below). Cells infected with wt AcNPV 
did not produce specific immunoreactivity. 
For pharmacological nalysis, membranes were subjected to 
a [3H]strychnine radioligand binding assay. In contrast to wild- 
type AcNPV infected cells, membranes of G6 infected cells 
exhibited [3H]strychnine binding displaceable by glycine, fl- 
alanine and taurine, a characteristic feature of the native GlyR 
(Fig. 1B). Scatchard analysis of displaceable [3H]strychnine 
binding revealed a dissociation constant (Kd) of 38.5 nM and 
a maximal number of [3H]strychnine binding sites (BmaO of 71.0 
pmol/mg protein (Fig. 1C). 
3.3. Subcellular localisation 
To study the subcellular distribution of the recombinant 
GlyR protein, G6 infected Sf9 cells were analysed by ftuores- 
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Fig. 2. Fluorescence microscopy of whole Sf9 cells infected with clone G6. Cells were incubated with mAb2 prior to fixation (A), or with mAb4 after 
methanol fixation (B). Non-infected cells as well as wt virus infected cells showed no staining above background level. The punctate staining pattern 
seen with mAb2 is likely to result from the formation of receptor aggregates by the divalent antibody. 
cence microscopy after staining with the monoclonal antibodies 
mAb2 or mAb4. In contrast to mAb4, which only binds dena- 
tured GlyR a subunits, mAb2 recognises the protein also in its 
native state [16] and can therefore be used for the staining of 
unfixed samples. Fig. 2A shows Sf9 cells 48 h post-infection 
that had been incubated with mAb2 prior to fixation to visual- 
ise the GIyR exposed on the cell surface. Intense fluorescence 
is observed at the cell perimeter that is typical of plasma mem- 
brane surface staining. Fig. 2B shows infected cells incubated 
with mAb4 after methanol fixation, i.e. after permeabilisation 
of the cell membrane. Now, intracellular perinuclear mem- 
branes were stained more intensely than the plasma membrane. 
Together, these data indicate that the receptor is efficiently 
incorporated into the plasma membrane; most of the recombi- 
nant protein, however, is found intracellularly, i.e. presumably 
within the endoplasmic reticulum and Golgi compartments. 
3.4. Functional analysis' 
Application of 5-100 mM glycine to infected Sf9 cells elicited 
inward currents of up to 9 nA at a holding potential o f -70  mV. 
The half-maximal ctivating lycine concentration (ECs0) was 
18.6 _+ 8.1 mM (mean ± S.D., n -- 9 cells), and the correspond- 
ing Hill coefficient 4.2 + 1.0 (Fig. 3A). Transmembrane cur- 
rents could be reversibly blocked by strychnine (Fig. 3B), with 
a half-maximal inhibitory concentration (ICs0) of 85.4 + 60 nM 
(n--5). The channels formed were activated not only by 
glycine, but also by micromolar concentrations of fl-alanine 
and taurine (Fig. 3B). Uninfected or wild-type AcNPV infected 
Sf9 cells were glycine-insensitive. Thus, expression of the 
human GlyR ~1 subunit in insect cells generates glycine-gated 
chloride channels, which display a pharmacology t pical of the 
mammalian GlyR (compare [2-5]). 
3.5. Solubilisation and purification 
The recombinant GlyR was solubilised from Sf9 cell mem- 
branes using the non-ionic detergent Triton X-100 according 
to the original purification protocol [10]. The recovery of 
[3H]strychnine binding sites after solubilisation was about 50%. 
To analyse its aggregation state, the solubilized receptor was 
subjected to sedimentation a alysis using sucrose gradient cen- 
trifugation. The majority of the receptor protein migrated at an 
apparent sedimentation coefficient of 7.5 S (Fig. 4A). No indi- 
cations were found for c~l subunit monomers, but some im- 
munoreactive material sedimented at11 S, which may represent 
receptor dimers. Additionally, some large aggregates were 
found at the bottom of the gradients. We conclude that most 
of the recombinant GIyR exists in a monodisperse solution 
upon Triton X-100 solubilisation. 
The recombinant GlyR was purified from the detergent ex- 
tract by affinity chromatography on 2-aminostrychnine aga- 
rose. In a typical purification experiment, about 30% of the 
[3H]strychnine binding sites applied to the column were recov- 
ered in the eluate, and the final yield of the binding sites in the 
glycine eluate was about 10% of the sites present in unsolubil- 
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Fig. 3. Functional analysis of G6 infected Sf9 cells. (A) Glycine elicited 
whole-cell currents a  a half-maximal concentration (ECs0) of 27.2 pM 
and with a Hill coefficient of h = 4.0. Strychnine inhibited these cur- 
rents with a half-maximal inhibitory concentration (ICs0) of 51.0 nM 
and a Hill coefficient of 1.0 (inset). The bars above the exemplary traces 
given denote the duration of glycine application, and the numbers 
correspond to glycine concentrations in/zM. I/I~ denotes relative cur- 
rent. (B) Current traces showing the activation of receptor by glycine 
(Gly, 20/zM), its reversible inhibition by strychnine (Stry, 0.3/~M), and 
the activation by fl-alanine (100 pM), and taurine (100/~M). 
ized membranes. This is comparable to the yield obtained with 
GlyR solubilized from mammalian spinal cord membranes 
[10,17]. In absolute numbers, one liter of cell culture containing 
about 1 × 109 cells, yielded about 400 pmol of affinity purified 
[3H]strychnine binding sites. 
SDS-PAGE of the purified preparation followed by silver 
staining revealed a predominant protein band at an apparent 
molecular weight of 48 kDa. Western blotting using mAb4 
identified the protein as GlyR ~ subunit (Fig. 4B). Thus, recom- 
binant ~1 homo-oligomeric GlyR can be purified to near homo- 
geneity from infected Sf9 cells. 
4. Discussion 
Our data show that Sf9 cells infected with a recombinant 
baculovirus carrying the GlyR ~1 subunit cDNA express a 
functional homo-oligomeric glycine receptor. Immunocyto- 
chemistry with intact cells visualised the recombinant receptor 
on the cell surface, indicating its incorporation i to the plasma 
membrane. With permeabilised cells, however, accumulation of
receptor protein within intracellular organelles was also appar- 
ent. 
Electrophysiological analysis of the infected Sf9 cells demon- 
strated that the recombinant GlyR responded to the agonists 
glycine, fl-alanine and taurine in a manner sensitive to the 
glycinergic antagonist strychnine. This confirmed that at least 
a fraction of the channel protein was correctly inserted into the 
plasma membrane. The affinity for glycine (ECs0 = 18.6 pM) 
and the degree of agonist cooperativity as expressed by the Hill 
coefficient of channel activation (h = 4.2) were similar to values 
previously found for GlyR ~1 receptors expressed in HEK-293 
cells (ECs0 = 29-100/zM, h = 1.6~4.2; see [4,5,18]). Preliminary 
single channel analysis in the outside-out patch clamp configu- 
ration revealed a main elementary conductance of88 pS accom- 
panied by subconductance states of 70 pS, 54 pS and 35 pS (N. 
Rundstr6m, unpublished results). These values are similar to 
the conductances of GlyR ~1 homo-oligomers in HEK-293 
cells (86, 64, 6, 30, and 18 pS; see [5]). 
Our electrophysiological d ta derived from intact cells are 
complemented by radioligand binding studies using Sf9 cell 
membrane homogenates. A dissociation constant (Kd) for 
[3H]strychnine of 38 nM is within the range of values found for 
native spinal cord membranes and HEK-293 ceils transiently 
expressing ~1 GIyR (2-64 riM; see [19-21,18,15]). The maximal 
number of strychnine binding sites (Bma x = 71 pmol/mg) ob- 
tained with the Sf9 cell system, however, significantly exceeds 
the values found for spinal cord membranes and transfected 
HEK-293 cells (2.4-17 pmol/mg) by 4- to 30-fold (compare: 
[19,20,18,15]). Thus, infected Sf9 cells express the GlyR to 
much higher levels than native neurons or even transiently 
expressing mammalian cells. 
GlyR ~1 receptors from expressing Sf9 cells were solubilised 
with the non-ionic detergent Triton X-100. This is an advantage 
to the digitonin/desoxycholate mixture reported in [7] to be 
equired for solubilizing the GlyR from Sf9 cell membranes, 
since Triton X-100 is much more economical for large-scale 
receptor preparations. Velocity gradient centrifugation of the 
solubilized material on sucrose gradients revealed that the ma- 
jority of the receptor migrates as a peak of 7.5 S. This corre- 
sponds to the sedimentation behaviour of native GlyR and that 
expressed in HEK-293 cells (7.7-7.9 S; [6,10]), which indicates 
that the predominant fraction of the receptor exists as ~1 ho- 
mopentamer in a monodisperse state. One-step affinity purifi- 
cation yielded a major protein band identical in molecular 
weight (48 kDa) and immunoreactivity to native GlyR a sub- 
units, with our preparation being much less contaminated by 
proteolytic degradation products as reported previously [7]. 
This might reflect a stabilisation of the protein when using 
Triton X-100 as a solubilising agent. For a better understanding 
of the fine structure of the GlyR, we plan to grow 2- and 
3-dimensional crystals for electron microscopy and X-ray dif- 
fraction analysis. The growth of protein crystals has been 
shown to be seriously hampered by autoaggregation phenom- 
ena [22]. The monodispersity of the solubilized recombinant 
GlyR demonstrated here thus may prove an important prereq- 
uisite for future high-resolution structure determination. 
Acknowledgements: Wethank Dr. A. Kirsch for help with immunofluo- 
rescence microscopy. This work was supported by th  Deutsche 
Forschungsgemeinschaft (Leibniz-Program and SFB 169) and the 
Fonds der Chemischen Industrie. 
J. Morr et al./FEBS Letters 368 (1995) 495~499 499 
A 
1.2 
> 
~= 1.0 
0 
G) t -  
O 0.8 
C 
E 
E 0.6 
mm 
.> 
¢~ 0.4 
m 
rr 
0.2 
0 15 
1.8 S 4.32 S 6.95 S 11.3 S 15.9 S 
7.5 S 
+ 
top bottom 
I , • ' ' " I r " t  , , 
5 10 
Fract ion number  
B 
kD~ 
66 
45 
36 
29 
1 2 
Fig. 4, Solubilisation and purification. (A) Velocity gradient centrifugation. A Triton X-100 extract from infected Sf9 cell membranes was subjected 
to sedimentation a 5-20% sucrose gradient. The major peak of mAb4 immunoreactivity migrated at an apparent sedimentation constant of 7.5 
S. Arrows indicate the position of marker proteins as specified in section 2. (B) Purification of the recombinant al GIyR. Solubilized GlyR was 
affinity-purified on an 2-aminostrychnine agarose column. SDS-PAGE and silver staining (lane 1), or Western blotting with mAb4 (lane 2), identified 
the major polypeptide of the column eluate as the 48kDa GlyR c~ subunit. 
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